KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Shares Outstanding (2019 - 2025)

Ginkgo Bioworks Holdings' Shares Outstanding history spans 7 years, with the latest figure at $58.2 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 0.68% year-over-year to $58.2 million; the TTM value through Dec 2025 reached $58.2 million, up 0.68%, while the annual FY2025 figure was $58.2 million, 0.68% up from the prior year.
  • Shares Outstanding reached $61.7 million in Q4 2025 per DNA's latest filing, up from $56.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $2.0 billion in Q2 2023 to a low of $408497.0 in Q3 2021.
  • Average Shares Outstanding over 5 years is $607.6 million, with a median of $56.1 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding: increased 26.45% in 2022, then plummeted 97.37% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $40.3 million in 2021, then grew by 17.41% to $47.3 million in 2022, then increased by 5.78% to $50.0 million in 2023, then grew by 15.55% to $57.8 million in 2024, then increased by 0.68% to $58.2 million in 2025.
  • Per Business Quant, the three most recent readings for DNA's Shares Outstanding are $58.2 million (Q4 2025), $60.3 million (Q3 2025), and $55.4 million (Q2 2025).